Petit et al. [31] found a reduction in vascular endothelial production factor after treatment of BC cells with human epidermal growth factor receptor-2 (Her-2) antibody, suggesting that Her-2 is associated with the expression and secretion of angiogenic factors. This evidence concerns the gene ERBB2 and breast cancer.